Zydus Wellness Q4 net rises 22 percent to Rs 36 crore Ruby Khatun Khatun27 May 2018 9:45 AM ISTNew Delhi: Zydus Wellness reported a 21.93 percent increase in consolidated net profit at Rs 36.25 crore for the quarter ended March 2018.The company...
AstraZeneca cancer drug hits second goal by extending survival Ruby Khatun Khatun27 May 2018 9:30 AM ISTLONDON: AstraZeneca’s immunotherapy drug Imfinzi has hit a second important goal by improving overall survival in lung cancer patients, boosting...
Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales Ruby Khatun Khatun27 May 2018 9:15 AM ISTMELBOURNE: An Australian court dismissed an appeal by the nation’s anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the...
Trace And Track: DTAB approves proposal to track 300 pharmaceutical brands Ruby Khatun Khatun26 May 2018 10:45 AM ISTNew Delhi: In order to curb the nuisance of spurious drugs in the domestic market the Drugs Technical Advisory Board (DTAB) has granted the approval...
Zydus Cadila gets USFDA nod for prostate drug Ruby Khatun Khatun26 May 2018 10:45 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Dutasteride and Tamsulosin Hydrochloride capsules.The drug...
Sun Pharma Q4 net up 7 percent at Rs 1,309 crore Ruby Khatun Khatun26 May 2018 10:30 AM ISTNew Delhi: Drug major Sun Pharma posted 6.96 percent increase in its consolidated net profit at Rs 1,308.96 crore for the fourth quarter ended March...
Pfizer to pay 23.85 million dollar to settle US co-payment kickback probe Ruby Khatun Khatun26 May 2018 10:15 AM ISTPfizer Inc agreed to pay $23.85 million to resolve U.S. charges that it used a purportedly independent charity to pay illegal kickbacks to Medicare...
FDA approves BioMarin rare metabolic disorder drug Ruby Khatun Khatun26 May 2018 9:45 AM ISTU.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the...
Novartis receives EU approval for biosimilar Zessly Ruby Khatun Khatun26 May 2018 9:30 AM ISTZURICH: Novartis said its Sandoz division received approval from the European Commission for its biosimilar Zessly (infliximab) in...
Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial Ruby Khatun Khatun25 May 2018 10:22 AM ISTA California jury ordered Johnson and Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to...
Merck's cancer drug Keytruda notches another trial success Ruby Khatun Khatun25 May 2018 9:30 AM ISTMerck & Co said its drug Keytruda helped patients with a certain type of lung cancer live longer and prevented the disease from spreading, helping...
Potential malfunction: Abbott recalling HeartMate 3 Left Ventricular Assist System, says USFDA Ruby Khatun Khatun24 May 2018 3:17 PM ISTThe US Food and Drug Administration (FDA) announced Abbott is recalling the HeartMate 3™ Left Ventricular Assist System. The FDA said it has...
